A double-blind, long-term, comparative study on quality of life, safety, and efficacy during treatment with amlodipine or enalapril in mild or moderate hypertensive patients: a multicenter study.

Author: EideI, HerlandO B, MidhaR, OmvikP, ThaulowE, TurnerR R

Paper Details 
Original Abstract of the Article :
Amlodipine (5-10 mg, once daily) and enalapril (10-40 mg, once daily) were compared in terms of quality of life, efficacy, and tolerability, in a multicenter, double-blind trial lasting for 50 weeks in 461 mild or moderate hypertensive patients. Both drugs were similarly effective in lowering blood ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/7522282

データ提供:米国国立医学図書館(NLM)

Amlodipine vs. Enalapril: A Head-to-Head Comparison for Hypertension

Hypertension, or high blood pressure, is a major health concern worldwide. This study compares the efficacy and safety of two common antihypertensive medications, amlodipine and enalapril, in patients with mild to moderate hypertension.

Finding the Right Fit for Hypertension Treatment

The researchers found that both amlodipine and enalapril were effective in lowering blood pressure while maintaining quality of life. The study also highlights the importance of considering individual factors like potential side effects when choosing a medication. This research provides valuable information for healthcare providers in making personalized treatment decisions for hypertension.

Navigating the World of Antihypertensive Medications

This study underscores the importance of careful medication selection for hypertension. It is like finding the right camel for a long desert journey. Each medication has its own strengths and weaknesses, and choosing the right one can make all the difference in managing hypertension effectively.

Dr. Camel's Conclusion

This study is a reminder that even when it comes to seemingly straightforward conditions like hypertension, there are nuances to consider. It's like choosing the right path through a vast desert: each route offers its own advantages and challenges. This research encourages us to carefully evaluate treatment options and choose the path that best suits our individual needs and circumstances.
Date :
  1. Date Completed 1994-10-17
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

7522282

DOI: Digital Object Identifier

7522282

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.